QDEL
QuidelOrtho Corp
$17.38
-0.86 (-4.71%)
At close · Jul 17
Market Cap
$1.19B
Shares
68,190,989
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.73B
-1.9%
FY2025
Net Income
-$1.13B
+44.8%
FY2025
Operating Margin
-33.67%
+36.8pp
FY2025
Diluted EPS
-$16.69
+45.4%
FY2025
Operating Cash Flow
$105.2M
+26.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|---|
| — | $2.66B | $2.73B | $2.78B | $3B | $3.27B | |
| — | — | — | -$163.5M | -$147.6M | -$75.7M | |
| — | $177.9M | $186.2M | $218.7M | $246.8M | $190.5M | |
| — | $758.6M | $746.3M | $766.8M | $763.2M | $621M | |
| — | $188M | $189.2M | $203.4M | $204.8M | $132.5M | |
| — | $447.8M | $442M | $453.4M | $457.2M | $283.6M | |
| — | -$983.6M | -$919.2M | -$1.96B | $139.1M | $843.7M | |
| — | — | -33.67% | -70.46% | 4.64% | 25.83% | |
| — | -$535.8M | -$477.2M | -$1.51B | $596.3M | $1.13B | |
| — | $188.7M | $177.6M | $163.5M | — | — | |
| — | -$1M | -$5.8M | -$7.1M | -$20.6M | -$8.1M | |
| — | — | $2.5M | $700K | -$3.6M | -$5.8M | |
| — | -$1.18B | -$1.11B | -$2.13B | -$29.1M | $735.9M | |
| — | $32.5M | $24.1M | -$79.5M | -$19M | $187.2M | |
| — | -$1.21B | -$1.13B | -$2.05B | -$10.1M | $548.7M | |
| — | — | -41.45% | -73.74% | -0.34% | 16.8% | |
| — | -$1.19B | -$1.11B | -$2.06B | $27.5M | $480.7M | |
| USD/shares | — | — | -$16.69 | -$30.54 | -$0.15 | $9.66 |
| USD/shares | $1.80 – $2.00* | — | -$16.69 | -$30.54 | -$0.15 | $9.56 |
| shares | — | — | 67.8M | 67.2M | 66.8M | 56.8M |
| shares | — | — | 67.8M | 67.2M | 66.8M | 57.4M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2025: $81.5M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
1.40×
Medical Devices median 2.19×
EV/EBIT
—
Medical Devices median 21.50×
P/E (TTM)
—
Medical Devices median 27.84×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | 2021-01-03 |
|---|---|---|---|---|---|---|
| North America Segment | $1,488,900,000 | $1,619,800,000 | $1,877,100,000 | $2,536,500,000 | $1,500,200,000 | $1,460,700,000 |
| EMEA Segment | $360,700,000 | $335,800,000 | $327,300,000 | $206,800,000 | $69,600,000 | $92,900,000 |
| China Segment | $334,700,000 | $325,000,000 | $310,100,000 | $220,000,000 | — | — |
| JPAC Segment | $293,000,000 | $279,400,000 | $272,700,000 | — | — | — |
| Latin America Segment | $252,900,000 | $222,900,000 | $210,600,000 | — | — | — |
| China | — | — | — | $220,000,000 | $58,000,000 | $62,400,000 |
| Other | — | — | — | $302,700,000 | $70,800,000 | $45,700,000 |
By Geography (USD)
| Component | 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | 2021-01-03 |
|---|---|---|---|---|---|---|
| Domestic Country | $1,436,600,000 | $1,568,800,000 | $1,829,400,000 | $2,451,700,000 | $1,415,500,000 | $1,452,400,000 |
| Foreign Country | $1,293,600,000 | $1,214,100,000 | $1,168,400,000 | $814,300,000 | $283,100,000 | $209,300,000 |
Key facts
CIK
1906324
CUSIP
219798105
13F (30d)
25 filings
24 filers
Visit website
Investor relations